GenomicMD is an innovative CLIA/CAP-accredited virtual lab that enables early detection and prevention of major common diseases (cardiovascular, cancers, diabetes, Alzheimer's, and blood clotting). Our flagship Lifetime Genomic Risk Assessment (LGRA) analyzes millions of genomic variants to derive relative lifetime risk by analyzing traditional rare pathogenic mutations and the polygenic background. The LGRA can identify 7-30x those at risk for tier 1 conditions, such as coronary artery disease, colorectal, breast, and prostate cancer, compared to single gene screening alone. This offers a superior risk stratification solution vs. family history surveys or monogenic testing. With GenomicMD, you can bring evidence-backed, preventive screening to develop more personalized treatment plans, assess the genomic contribution of risk for those with disease, improve patient outcomes, and attract new patients.
GenomicMD offers reimbursable tier 1 and self-pay panels for up to 20 conditions. Physicians can register on our web-based Provider Portal and order tests in a few clicks. Post-order, patients input their address to receive an at-home saliva collection kit, which can be easily returned via USPS. Results are returned to the ordering provider via the portal (or EHR integration) in 3-4 weeks.
GenomicMD is in-network with United Health, several Blue's, and out-of-network with many other payers.
Please get in touch with support@genomicmd.com if you would like to set up a time to connect during the show.